Quick Answer
Axogen, Inc. reported Cash and Equivalents of $35.55 million for fiscal year 2025.
Axogen, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $35.55M | +29.0% |
| 2024 | $27.55M | -11.2% |
| 2023 | $31.02M | +103.0% |
| 2022 | $15.28M | -53.3% |
| 2021 | $32.76M | -32.8% |
| 2020 | $48.77M | +36.5% |
| 2019 | $35.72M | +47.0% |
| 2018 | $24.29M | -33.5% |
| 2017 | $36.51M | +21.6% |
| 2016 | $30.01M | +15.8% |
| 2015 | $25.91M | +215.4% |
| 2014 | $8.22M | -59.1% |
| 2013 | $20.07M | +44.3% |
| 2012 | $13.91M | +69.8% |
| 2011 | $8.19M | +355.3% |
| 2010 | $1.80M | +536.2% |
| 2009 | $282.8K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $23.90M | +28.1% | +19.3% |
| June 30, 2025 | $20.04M | +4.4% | +10.7% |
| March 31, 2025 | $18.10M | +15.2% | -34.3% |
| December 31, 2024 | $27.55M | -11.2% | +47.6% |
| September 30, 2024 | $18.66M | -40.0% | -2.7% |
| June 30, 2024 | $19.19M | -17.4% | +22.1% |
| March 31, 2024 | $15.71M | +103.9% | -49.4% |
| December 31, 2023 | $31.02M | +103.0% | -0.2% |
- Axogen, Inc. showed an increase of +29.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, Axogen, Inc.’s cash and equivalents has grown by 12470.0% (from $282.8 thousand to $35.55 million).
- The most recent figure is from Axogen, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: